We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.77B
AUM Growth
-$144M
Cap. Flow
-$222M
Cap. Flow %
-12.52%
Top 10 Hldgs %
26.42%
Holding
490
New
173
Increased
53
Reduced
63
Closed
192

Sector Composition

Rank Sector Weight
1 Industrials 9.01%
2 Consumer Discretionary 8.07%
3 Communication Services 6.05%
4 Technology 4.63%
5 Consumer Staples 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
226
Ollie's Bargain Outlet
OLLI
$4.17B
$1.2M 0.07%
45,600
+3,600
+9% +$93.9K
ZAYO
227
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.19M 0.07%
40,100
+18,500
+86% +$535K
NVTR
228
DELISTED
Nuvectra Corporation Common Stock
NVTR
$1.15M 0.06%
165,910
-4,400
-3% -$30.2K
APC
229
DELISTED
Anadarko Petroleum
APC
$1.14M 0.06%
+18,000
New +$1M
SOHU
230
CALL
Sohu.com
SOHU
$346M
$1.13M 0.06%
+25,500
New +$1.03M
PF
231
DELISTED
Pinnacle Foods, Inc.
PF
$1.12M 0.06%
+22,300
New +$1.1M
AEO icon
232
American Eagle Outfitters
AEO
$3.04B
$1.12M 0.06%
+62,500
New +$1.12M
USO icon
233
CALL
United States Oil Fund
USO
$2B
$1.09M 0.06%
+12,500
New +$1.05M
MCD icon
234
McDonald's
MCD
$194B
$1.08M 0.06%
+9,400
New +$1.11M
MRIN
235
DELISTED
Marin Software
MRIN
$1.08M 0.06%
10,220
-5,351
-34% -$559K
CTSH icon
236
Cognizant
CTSH
$23.8B
$1.08M 0.06%
+22,611
New +$1.29M
CLVS
237
DELISTED
Clovis Oncology, Inc.
CLVS
$1.02M 0.06%
28,300
-307,900
-92% -$6.61M
ALIM
238
DELISTED
Alimera Sciences
ALIM
$996K 0.06%
44,557
-95,576
-68% -$2.2M
JOYY
239
CALL
JOYY Inc
JOYY
$3.77B
$986K 0.06%
+18,500
New +$845K
OOMA icon
240
Ooma
OOMA
$608M
$955K 0.05%
105,153
-196,540
-65% -$1.7M
NAV
241
DELISTED
Navistar International
NAV
$948K 0.05%
+41,400
New +$630K
AMRN
242
Amarin Corp
AMRN
$293M
$944K 0.05%
14,800
-6,200
-30% -$347K
MTZ icon
243
PUT
MasTec
MTZ
$24.7B
$928K 0.05%
+31,200
New +$856K
TEVA icon
244
CALL
Teva Pharmaceuticals
TEVA
$36.9B
$920K 0.05%
20,000
-180,000
-90% -$9.39M
CF icon
245
CALL
CF Industries
CF
$18.9B
$913K 0.05%
37,500
-414,100
-92% -$10.1M
IVV icon
246
iShares Core S&P 500 ETF
IVV
$871B
$870K 0.05%
+4,000
New +$870K
EMN icon
247
Eastman Chemical
EMN
$7.79B
$860K 0.05%
+12,700
New +$852K
XRAY icon
248
Dentsply Sirona
XRAY
$2.7B
$856K 0.05%
+14,400
New +$885K
ACHC icon
249
Acadia Healthcare
ACHC
$3.01B
$842K 0.05%
+17,000
New +$885K
BLOX
250
DELISTED
Infoblox Inc
BLOX
$796K 0.05%
+30,200
New +$636K

Similar funds

J. Goldman & Co's Q3 2016 Portfolio in Review

As of Q3 2016, J. Goldman & Co held 490 positions worth $1.77B, down 7.5% from $1.91B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

J. Goldman & Co withdrew a net $222M in Q3 2016, closing 192 positions and reducing 63 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $32.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 9% of assets, up from 7.6% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, J. Goldman & Co opened a new position in Salesforce worth $19.8M.

  • J. Goldman & Co's largest Q3 2016 buy was Salesforce: 278,200 shares worth $19.8M.
  • J. Goldman & Co added most to National Beverage in Q3 2016, an estimated $16.6M increase.
  • J. Goldman & Co's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $33.9M.
  • J. Goldman & Co fully exited State Street SPDR S&P Retail ETF in Q3 2016, selling an estimated $32.2M.
  • J. Goldman & Co's ten largest holdings make up 26% of its $1.77B portfolio in Q3 2016.
  • J. Goldman & Co opened 173 new positions and closed 192 in Q3 2016.
  • J. Goldman & Co's portfolio value fell 7.5% quarter-over-quarter to $1.77B.

Based on J. Goldman & Co's 13F filing for Q3 2016, filed 14 Nov 2016.